With reference to the Health and Safety Executive's (HSE) report entitled Agency Opinion on the classification and labelling of lithium carbonate [1] lithium chloride [2] and lithium hydroxide [3], published in August 2013, whether the HSE plans to initiate the Article 37A process; and what discussions she has had with the HSE on that issue.
The Health and Safety Executive (HSE) is considering whether to initiate the Article 37A process under the GB Classification, Labelling and Packaging Regulation (GB CLP) following publication of the Agency Opinion on the classification and labelling of lithium carbonate [1] lithium chloride [2] and lithium hydroxide [3] in August 2023. Under Article 37A, HSE, as the GB CLP Agency, may submit a proposal for a new or revised GB mandatory classification and labelling requirement when there is evidence of new scientific data or information that may lead to a new or revised mandatory classification and labelling for a priority hazard class, such as carcinogenicity, mutagenicity or reproductive toxicity. There is no statutory time limit on HSE to prepare and submit a proposal. HSE regulatory and scientific specialists are investigating the evidence and new scientific data made available and, if necessary, seeking any additional information or consulting other departments or agencies. HSE is continuing to engage with stakeholders during this process. No discussions have been held on this issue between the Secretary of State for Work and Pensions and HSE.